Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina
Claudio Martín, Lorena Lupinacci, Florencia Perazzo, Carlos Bas, Omar Carranza, Carmen Puparelli, Rubén Dario Kowalyszyn, Ignacio Magrí, Mirta Varela, Eduardo Richardet, Karina Vera, Silvia Foglia, Ignacio Jerez, Enrique Aman, Gastón Lucas Martinengo, Emilio Batagelj, Alejandro Dri, N. Pilnik, Guillermo M. Roa, Pablo Mandó, Florencia Tsou, Gonzálo Recondo, Federico Cayol, Marcos A. Flores, S. Sena, Claudia Bagnes, Federico Waisberg, J.N. Minatta, Manglio Rizzo
Topics & Concepts
MedicineNivolumabInternal medicineLung cancerInterquartile rangeHazard ratioOncologyToxicityRetrospective cohort studyChemotherapyUnivariate analysisProgressive diseaseSurgeryCancerMultivariate analysisConfidence intervalImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentCAR-T cell therapy research